Trial Profile
Phase 3 reboxetine treatment in depressed children and adolescents an 8-week, open study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Reboxetine (Primary) ; Fluoxetine
- Indications Depressive disorders; Dysthymic disorder
- Focus Therapeutic Use